Drug Profile
Deferitazole
Alternative Names: Deferitazole magnesium; FBS-0701; SHP602; SPD-602; SSP-004184; SSP-004184AQ; SSP-004184SSLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator FerroKin BioSciences
- Class Heterocyclic acids; Small molecules; Thiazoles
- Mechanism of Action Iron chelating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Iron overload
Most Recent Events
- 08 Jan 2019 Shire has been acquired and merged into Takeda
- 18 Mar 2014 Suspended - Phase-I for Iron overload in Australia (PO)
- 18 Mar 2014 Suspended - Phase-II for Iron overload in USA, Canada, Italy, Lebanon, Thailand, Turkey and United Kingdom before March 2014 (PO)